Alligator Bioscience AB (publ) (STO:ATORX)
0.0366
-0.0002 (-0.54%)
Aug 13, 2026, 5:29 PM CET
Alligator Bioscience AB Market Cap
Alligator Bioscience AB has a market cap or net worth of 23.11 million as of August 13, 2026. Its market cap has decreased by -85.73% in one year.
Market Cap
23.11M
Enterprise Value
22.52M
Revenue
520.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since November 23, 2016, Alligator Bioscience AB's market cap has decreased from 2.67B to 23.11M, a decrease of -99.13%. That is a compound annual growth rate of -38.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 23.11M | 56.59% |
| Dec 30, 2025 | 14.76M | -92.20% |
| Dec 30, 2024 | 189.17M | -58.27% |
| Dec 29, 2023 | 453.33M | 32.59% |
| Dec 30, 2022 | 341.91M | -39.69% |
| Dec 30, 2021 | 566.90M | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 73.02M |
| Pila Pharma AB | 60.99M |
| Disruptive Pharma AB | 55.82M |
| 2cureX AB | 52.77M |
| Modus Therapeutics Holding AB | 45.98M |
| Fluicell AB | 42.04M |
| ExpreS2ion Biotech Holding AB | 34.67M |